Switch to
More onapp

Epigral Ltd

EPIGRAL
2,086.1538.60 (-1.82%)
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

Go Pro! to unlock score, rank

and other metrics

How to use scorecard? Learn more

OverviewForecastsFinancialsPeersHoldingsNewsEvents

Epigral Ltd

EPIGRAL
MaterialsCommodity Chemicals
SmallcapWith a market cap of ₹9,311 cr, stock is ranked 581
High RiskStock is 3.73x as volatile as Nifty
2,086.1538.60 (-1.82%)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

Go Pro! to unlock score, rank

and other metrics

How to use scorecard? Learn more

MaterialsCommodity Chemicals
SmallcapWith a market cap of ₹9,311 cr, stock is ranked 581
High RiskStock is 3.73x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
31.72
PB RatioPB Ratio
7.11
Dividend YieldDiv. Yield
0.22%
Sector PESector PE
31.17
Sector PBSector PB
3.55
Sector Div YldSctr Div Yld
1.31%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Epigral Limited (formerly Meghmani Finechem Limited) is a manufacturer of essential chemicals, primarily focused on the production of chlor alkali and its derivatives, used across various industries.

PeersCompare with peers 

Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20212022202320240.831.562.201.940.100.250.350.20
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

General Updates 
Announced OnDec 5, 2024

Epigral Limited has informed the Exchange about Partial Withdrawal of Reclassification Application submitted under 31A of the Listing Regulations. | Download

Epigral Limited has informed the Exchange about Partial Withdrawal of Reclassification Application submitted under 31A of the Listing Regulations. | Download

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnNov 28, 2024

Epigral Limited has informed the Exchange about Schedule of meet with Investor / Analyst. | Download

Epigral Limited has informed the Exchange about Schedule of meet with Investor / Analyst. | Download

Cash Dividend 
Ex. DateJul 2, 2024

Final • Div/Share: ₹ 5

See all events

© Powered byTickertape.ViewEPIGRALon 

EmailHelpBlog

NSE & BSE – SEBI Registration No: INZ000031633 | CDSL - SEBI  Registration No: IN-DP-431-2019

Zerodha - NSE & BSE – SEBI Reg. No.: INZ000031633
Zerodha - CDSL - SEBI Reg. No: IN-DP-431-2019